Stocks
BridgeBio (BBIO) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 12.7% | 91.1% | 69.2% | 8.14% | 14.0% | 2.19% | |||
| Changes by years, y/y, % | +78pp | -22pp | -61pp | +6pp | +2.6% | ||||
BridgeBio. CAPEX/Revenue, %
BridgeBio. CAPEX/Revenue, changes, pp
BridgeBio (BBIO) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| CAPEX/Revenue, % | 26.1% | 10.5% | 24.9% | 0.71% | 112.9% | 2.19% | ||
| Changes by years, y/y, % | +21pp | -214pp | -18pp | +0pp | +87pp | |||
| Changes by quarters, q/q, % | +25pp | -16pp | +14pp | -24pp | +112pp | |||
